Last edition
News about Market
Lupin Launches Diabetes Drug Combination in the US
Lupin launches dapagliflozin and metformin extended-release tablets in the US, offering a bioequivalent and cost-effective alternative for type 2 diabetes management.
Market | 22/04/2026 | By News Bureau | 225
Merck Launches Bio-Based Solvents for Sustainable HPLC Applications
Merck introduces bio-based HPLC solvents made from renewable feedstocks, offering lower carbon emissions while maintaining performance for advanced laboratory and analytical applications.
Market | 22/04/2026 | By News Bureau | 312
Raay Neo Pharma Launches Operations with Focus on Expanding Access to Medicines
Raay Neo Pharma plans to introduce 90 plus formulations across acute and specialty therapies along with its entry in the India’s Pharmaceutical sector, aiming to strengthen healthcare access across multiple Indian states through a scalable and patient-centric model.<br />
Market | 22/04/2026 | By News Bureau | 247
SynSmart and Amporin Partner to Develop Small Molecule Therapies for Degenerative Diseases
SynSmart and Amporin collaborate to develop breakthrough small molecule therapeutics for degenerative diseases, with SynSmart creating a library of novel membrane-protecting molecules at its Mumbai research facility.
Market | 22/04/2026 | By News Bureau | 180
Asahi Kasei expands its global pharmaceutical footprint with the acquisition of Aicuris, strengthening its pipeline in infectious diseases and advancing treatments for immunocompromised patients.
Market | 21/04/2026 | By News Bureau | 145
Rise in Autoimmune Diseases Reported Across Karnataka, Warn Experts
During Rheumatology Awareness Month, experts highlight increasing cases of autoimmune and rheumatology disorders in Bengaluru and smaller towns, stressing early diagnosis to prevent severe complications and delayed treatment outcomes.
Market | 21/04/2026 | By News Bureau | 184
BioMed X Launches First Research Team in France to Advance AI-Driven Antibody Design
BioMed X launches AI-focused antibody research team in France, aiming to accelerate development of next-generation biologic therapies for cancer and immune diseases.
Market | 21/04/2026 | By News Bureau | 191
Piramal Pharma Solutions Expands ADC Capabilities with Ajinomoto Bio-Pharma Services Pact
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to accelerate ADC development and manufacturing, enabling access to AJICAP technology.
Market | 20/04/2026 | By News Bureau | 224
Mabwell Signs Malaysia Deal for Denosumab Biosimilars
Mabwell signs a Malaysia licensing deal for denosumab biosimilars, with its partner leading registration and commercialisation while Mabwell handles development, production and supply, strengthening its Asia market expansion strategy.
Market | 20/04/2026 | By News Bureau | 144
Global Study Identifies Most Effective Strategies to Increase Vaccine Uptake
Research in The BMJ finds that expanded access, community engagement, and financial incentives significantly improve vaccination rates across age groups and underserved populations.
Market | 17/04/2026 | By News Bureau | 147
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy